Apogee Therapeutics Ratios (2022-2026) | APGE

Ratios Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Efficiency
Assets Average (Quarter) 278.54M413.91M612.53M812.16M788.47M765.12M734.06M685.97M641.97M781.65M1,115.39M
Equity Average (Quarter) -14.26M-29.74M-41.02M-55.53M172.41M394.58M590.70M787.56M754.02M725.60M695.08M646.38M602.87M745.11M1,079.84M
Invested Capital (Quarter) -4.43M-24.09M-35.39M-46.64M-64.42M409.24M379.91M801.48M773.64M734.40M716.79M673.36M619.40M586.34M903.88M1,255.79M
Leverage & Solvency
Equity Ratio (Quarter) -0.23-0.490.960.950.970.970.950.950.940.940.940.960.97
Valuation
Enterprise Value (Quarter) -4.97M-151.89M-125.10M-422.87M-395.46M-816.20M-676.20M-526.05M-520.65M-513.33M-505.39M-527.29M-730.19M-1059.90M
Return Ratios
Return on Capital Employed (Quarter) -26.76%-4.48%-7.30%-8.68%-13.60%-5.19%-9.01%-14.09%-17.24%-7.12%-6.78%
Return on Invested Capital (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter) 0.01%0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%